skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What is the explanation for the drop, or inconsistency, of quarterly revenue from CRSP and is this a concern?

2019-09: $ 211 M
2019-12: $ 77 M
2020-03: $ 0.157 M
2020-06: $ 0.044 M
2020-09: $ 0.148 M

Their annual revenue in 2019 was $ 289.59 M and it does not look like they will come anywhere close to that number in 2021!

Thanks.
Read Answer Asked by Robert on January 26, 2021
Q: I currently own some ARKG and CRSP. If you were to buy a few more individual stocks in this space and had a long term time frame and high risk tolerance what would you buy?
Read Answer Asked by Richard on January 25, 2021
Q: PLX is an Israeli Bio co. not showing in your system.
I bought a small position 6 months ago as I am very interested in the diseases they are working to try to alleviate and potentially cure. It has gone up in price nicely this week after company update to shareholders.
Would appreciate your views. Is this a hold or worth buying more at this stage. John.
Read Answer Asked by JOHN on January 21, 2021
Q: Hello Peter, Ryan, and 5i Team,

I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
Read Answer Asked by Bradley on January 20, 2021
Q: Hello team,

Of the 3 companies above, BEAM has 3 times more shares sold short (18% of the float) but all three have been on a run.
If you could buy only one which one would you choose today as a great company for a long-term hold and which one you would rather avoid? And of course why?

Thanks for making investment accessible for ordinary people.
Read Answer Asked by Saeed on January 20, 2021
Q: In your answer to a question recently asked on Genomics, your suggestion was to buy an ETF such as ARKG or EAGB. You also mentioned that if so inclined you could start adding small amounts in specific stocks which of course be riskier. Would you be able to suggest 3 or 4 of these stocks either US or Canadian, preferably at least one of each.
Read Answer Asked by Rob on January 19, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!